Abstract
A knowledge-based design strategy led to the discovery of several new series of potent and orally bioavailable CRTh2 antagonists where a bicyclic heteroaromatic ring serves as the central core. Structure–kinetic relationships (SKR) opened up the possibility of long receptor residence times.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have